Fusion, Derived From T(12,16) Malignant Liposarcoma (Human)
Spezies
Human
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
Produktmerkmale
This is a synthetic peptide designed for use in combination with anti-FUS antibody (Catalog #: ARP40278_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Aufreinigung
Purified
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
Fusion, Derived From T(12,16) Malignant Liposarcoma (Human)
Hintergrund
FUS binds both single-stranded and double-stranded DNA and promotes ATP-independent annealing of complementary single-stranded DNAs and D-loop formation in superhelical double-stranded DNA. FUS may play a role in maintenance of genomic integrity.
Alias Symbols: FUS-CHOP, FUS1, TLS, ALS6, POMP75, HNRNPP2
Protein Interaction Partner: FUS,GRIN1,GRIN2D,ILF3,POLR2A,PRMT1,PTBP1,RELA,RXRA,SF1,SFPQ,SPI1,SRRM1,SRSF10,SRSF2,SRSF4,THRA,YBX1,ZMYM2,EIF6,ILF3,OTUB1,PRMT1,PTBP2,RELA,RXRA,SARNP,SF1,SPI1,SRRM1,SRSF10,THRA,USF2,YBX1,ZMYM2